Built Here First: The Ideas TRT Plus Pioneered

Quick answer

A lot of the ideas now common in TRT and peptide apps started here: the dose calculators, the rotation planners, the half-life charts... but those are the easy pieces, and they're all the copycats ever take. The whole engine framework and the actual protocol optimization, the part that matters, is still only in TRT Plus.

One developer, one obsession

Bringing any single one of these to market would be impressive. Bringing all of them, in one app, is a different thing entirely.

Some of it has since shown up in other apps, but only ever the easy pieces: the tracker, the reminders, the rotation planner. The engine underneath, the models and the protocol optimization, hasn't been matched, because logging a protocol is the easy part; getting it right is the part nobody else has built.

The developer's journey to build TRT Plus

Appreciating the importance of precision started two decades before at Crown Scientific, calibrating CAD specifications for pharmaceuticals. An error here becomes an incorrect dose at scale, with the medical and liability risk that carries. Getting a dose exactly right was the whole point then, and is one of the foundation features of TRT Plus today.

The two decades since were spent in financial markets as a lead developer, repeatedly appointed to the highest-profile projects, building the data pipelines and automation that route and reconcile billions in trades, where an error is measured in millions.

Two very different worlds, overlapping in precision and provability. Some of the best innovations are cross-overs, concepts carried in from a parallel field. A few of these echoed ideas shaped this build directly:

A compound's concentration over time is a stack of exponentially decaying doses settling into a steady state superposition. Once it's there, PTF% measures how much testosterone swings, the way volatility measures the swing of a market.
A hematocrit ceiling that flexes with your cardiovascular health is a risk limit that flexes with the fundamentals: strong markers earn more room, the way strong company ratings earn more exposure.
The Testimator™ scaling your predicted testosterone up or down as you change a protocol is, mathematically, not far from how a gearing ratio scales exposure in a leveraged fund.
It's also why the bloodwork analytics engine runs deterministically first, with AI used only to interpret the finished result, never to improvise the numbers.

A timeline of firsts

Every date below is a public App Store and Google Play release.

2023

Free testosterone with bound-fraction visualization (April 2023). The first app to show free testosterone against its bound fractions as a readable pie chart, instead of a single number with no context.
Closed-loop dose calculator with syringe diagram (May 2023). The first closed-loop calculator: enter a dose to get the volume, or a volume to get the dose, recalculating live as frequency or concentration changes, shown on a visual syringe.
The Testimator™ (May 2023). The first to model your individual response to testosterone and predict your levels on protocols you haven't run yet, anchored to your own bloodwork, with reference ranges that update as your results evolve. A competitor later built an entire standalone app around this one idea, but assumed blood is always drawn at peak, so the whole model was flawed from the start.
Peak-to-Trough Fluctuation, PTF% (May 2023). The first to put a real number on how far your levels actually swing between peak and trough. It comes from the superposition of your overlapping doses, not the sawtooth most apps draw, and it's the value that tracks stability and side effects. It's also a genuinely hard calculation, raw dog coded in 2023, before AI.

2024

The Biomarker Dashboard (September 2024). Your bloodwork scorecard on a single screenshot instead of a long cryptic list: an overall health score and the ratios that matter, red, amber, and green pulling your eye to what needs attention, high and low flags that read at a glance, trimmed to only the markers that move the needle on TRT, with a tap into each marker's personalized range and knowledge base. Built to be taken in like a trading dashboard, not scrolled like a lab printout.
Enhanced reference ranges (September 2024). The first app to score your bloodwork against ranges built for men on TRT and enhanced protocols, derived from de-identified real-world clinic data rather than the general population. General "optimal range" products existed for the healthy population, but TRT- and enhanced-specific ranges had lived only in clinics and coaching circles until now.
Forward-looking injection rotation planner (November 2024). The first to plan your injection sites forward across your protocol, rather than just logging where you've already been.

2025

Zakharov, Mazer and Södergård free-T methods (October 2025). The first TRT app to bring the Zakharov method to free-testosterone estimation, alongside Mazer and Södergård and the original Vermeulen. Zakharov is the standout for enhanced and high-testosterone profiles.
Route-specific pharmacokinetic models (October 2025). Orals, aqueous suspensions, subcutaneous peptides, and oil esters each modeled by how they are actually absorbed.
The Clogging Quartet (October 2025). Coined here: a framework for the four atherosclerosis markers most relevant to TRT, ApoB, CRP, HbA1c, and blood pressure, whose combined risk is greater than the sum of the parts.
Compound stacking in the syringe (October 2025). Combine multiple compounds into a single injection and verify the volumes visually, the way people running several enhancement compounds actually load one syringe to cut down the number of injections.

2026

The A:E ratio, Total Androgenic Load (March 2026). The first androgen-to-estrogen model to fold in DHT's substantially greater receptor affinity and its non-linear amplification at the tissue level, using an asymmetric model, for a truer read of hormonal balance than a flat T:E ratio.
Personalized testosterone reference range with a dynamic hematocrit ceiling (April 2026). The first to earn your tolerance for a marker from your own cardiovascular and metabolic profile, rather than reading it off a population bell curve.
The Cardio-Metabolic Cascade (May 2026). The framework underneath that personalization: your cardiovascular and metabolic markers feed two connected cascades, one that earns your testosterone range, one that gates your hematocrit ceiling. Blood Pressure, lipids, Body Fat, CRP and HbA1c are weighed together, the way a clinician interprets them.
Transdermal saturation model and cream-to-injectable converter (May 2026). The first to model cream absorption with a saturation function site by site and express it as a weekly injectable-equivalent, so a topical protocol is directly comparable to an injectable one, upper saturation limits included.
Dose Titration (July 2026). The first titration planner that calculates the steps for you, in the real graduation increments your syringe can actually draw, and stays flexible on step cadence, duration, and start date for the ramp or taper. It even recalibrates if you adjust the protocol mid-plan.

Why it's built this way

TRT Plus is the output of one developer's decision that the optimization space deserved original thinking and real engineering. The community gets the benefit: ideas the category hadn't seen, built with pharmaceutical-grade precision and financial-grade engineering, documented and cited, in a consumer app.

If you're a clinician, a coach, or someone who reads the methodology before trusting a number, the engine page is the place to start. Look under the hood.

Frequently asked questions

Is the methodology actually documented?

Yes. The models, formulas, and cited studies are published on the engine page, including the multi-route PK model, the A:E Androgenic Load formula, and the Cardio-Metabolic Cascade.

Can clinicians and coaches use it with clients?

TRT Plus is a consumer app, and its output is designed to inform the conversation with a healthcare provider, not replace it.

Who is the developer?

Nathan, founder and developer @ TRT Plus, designed, built, and maintains all of it: a career that began in pharmaceuticals and ran through two decades of financial-systems engineering.

This article is for informational purposes only and does not constitute medical advice. Consult with your healthcare provider before making medical decisions.

Read the methodology

Every model, formula, and cited study behind these firsts is published on the engine page. See the engine · Get TRT Plus.